MacFarlan Smith is a pharmaceutical manufacturing company based in Edinburgh, Scotland, founded in 1815. After its sale from Johnson Matthey in June 2022 to Altaris Capital Partners, Macfarlan Smith rebranded as Veranova. Veranova is a CDMO specialising in the development and manufacturing of specialist and complex active pharmaceutical ingredients, or APIs. It has facilities across Europe and North America.
After expanding to Edinburgh in 1820, Duncan dissolved the partnership with the Perth shop and started a new partnership in Edinburgh with William Flockhart (also from Kinross), which in 1833 was called Duncan & Flockhart, incorporated three years later. Following the death of John Duncan (c. 1839) the firm was taken over by his son Dr James Duncan. In the same year the firm began to manufacture lactucarium, and from 1847 supplied Chloroform to Sir James Simpson. The firm expanded, and supplied chloroform to both the British Army, Royal Navy and British Red Cross during both world wars. After the start of World War I, the company established a drug growing farm at Warriston, to assure supply.
In 1958, while trying to develop dental anesthetic Lignocaine, the company had discovered the bitterest known substance, Denatonium. Developed as a denaturant for industrial alcohol, in the 1970s it was commercially marketed as Bitrex, a safety additive for household products such as liquid detergents. Tesco was the first supermarket to display the Bitrex brand on their products.
In 1963 the company reproduced highly potent Etorphine, in a research group led by Professor Kenneth Bentley (Bentley compounds).Bentley KW, Hardy DG. "New potent analgesics in the morphine series." Proceedings of the Chemical Society. 1963;220.
Bought through a management buy out in 1990, Macfarlan Smith was floated on the London Stock Exchange in 1993 under the holding company Meconic, the Greek language word for poppy.
In 2001, Johnson Matthey plc bought Meconic, and merged it into its Fine Chemical and Catalysts division.
In late 2006, the British government permitted MacFarlan Smith to cultivate opium poppies in the United Kingdom for medicinal reasons, in response to increasing global prices for concentrate of poppy straw, the company's main raw material. A major opium poppy field is based in Didcot, England. As of 2012 they were growing in Dorset, Hampshire, Oxfordshire & Lincolnshire as a spring sown breakcrop recognised under the single payment scheme farm subsidy. The Office of Fair Trading has alerted the government to their monopoly position on growing in the UK and worldwide production of diamorphine and recommended consideration. The government's response advocated the status quo, being concerned interference might cause the company to stop production.
The British government has since contradicted the Home Office's suggestion that opium cultivation can be legalized in Afghanistan for exports to the United Kingdom, helping lower poverty and internal fighting whilst helping the National Health Service to meet the high demand for morphine and heroin. Opium poppy cultivation in the United Kingdom does not need a licence, but a licence is required for those wishing to extract opium for medicinal products.The painkilling fields: England's opium poppies that tackle the NHS morphine crisis, Press release , 15 September 2007.
Macfarlan Smith now claims to be one of the world's leading manufacturer of opiate alkaloids. Together with sister companies within the Johnson Matthey group, they can provide full spectrum drug development, from drug discovery through to bulk production.
T&H Smith
Foundation
Present
|
|